Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by inthnoon Dec 12, 2001 3:26pm
2022 Views
Post# 4515963

predictions and news

predictions and newsOkay here we go; Everyone is worried about syb,"Don't!" The problem if any will just go away soon enough.One can speculate in syb if you want because it would probabally take a pop up on any positive news that either onc or syb would make.One thing to remember now is that syb is just a holding company now,and, generally holding companies will trade at a discount to the market. It's just the nature of the beast. Of note to remember is that people south of us are just sitting and waiting for positive phase 1 results. This has been stated before by onc management. Lots of money waiting for a place to go. I am not trying to pump up onc,usually I just stick as close to the facts as I can. With all that we know to date can anyone actually think of anything negative that onc could announce.We must remember that they are a speculative company and with that always comes associated risks.Buyer beware and all that,but this can happen with any company.Nortel,Rim,the list goes on.(This is not a direct comparison to these companies,it's just to show that there is risk with any company no matter how solid it may appear.) Onc has stated on numerous occasions that they have not reached a toxic level yet.They don't know if there really is one.So this bodes well already for phase 1 news release.I know that we all want efficacy also and this will happen most likely on an interim basis as results will still be coming in from patients in the later stages of the trials. Remember to be able to break down the efficacy results patient by patient as they come in because not all cancers are ras-activated. I still think a pharma will happen early q1-2002. AND-NEWS that we want-sooner than you think! Good luck to all and please be prudent with your investments. inthno
Bullboard Posts